tiprankstipranks
Trending News
More News >
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market

Lifecore Biomedical (LFCR) Financial Statements

Compare
150 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently $291.11M. The company's EPS TTM is $; its P/E ratio is -5.96; Lifecore Biomedical is scheduled to report earnings on January 1, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 128.87M$ 128.26M$ 103.27M$ 111.27M$ 100.87M
Gross Profit$ 40.30M$ 41.85M$ 27.98M$ 39.07M$ 38.94M
Operating Income$ -17.25M$ -8.84M$ -21.80M$ -11.79M$ -8.82M
EBITDA$ -8.81M$ 35.60M$ -33.17M$ 12.84M$ -987.00K
Net Income$ -38.72M$ 12.01M$ -99.56M$ -116.72M$ -32.29M
Balance Sheet
Cash & Short-Term Investments$ 8.27M$ 8.46M$ 19.09M$ 991.00K$ 1.16M
Total Assets$ 239.34M$ 253.96M$ 253.54M$ 274.70M$ 502.92M
Total Debt$ 130.82M$ 133.57M$ 112.62M$ 247.78M$ 215.86M
Net Debt$ 122.56M$ 125.11M$ 93.53M$ 246.79M$ 214.70M
Total Liabilities$ 238.01M$ 242.65M$ 257.77M$ 186.88M$ 300.14M
Stockholders' Equity$ 1.34M$ 11.31M$ -4.23M$ 87.82M$ 202.78M
Cash Flow
Free Cash Flow$ -13.62M$ -18.14M$ -38.92M$ -52.53M$ -8.75M
Operating Cash Flow$ -206.00K$ 257.00K$ -17.44M$ -22.59M$ 16.47M
Investing Cash Flow$ -6.42M$ -18.39M$ -4.81M$ 79.96M$ -12.31M
Financing Cash Flow$ 6.42M$ 7.51M$ 39.70M$ -57.02M$ -3.42M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.